J C Karper1, S C A de Jager, M M Ewing, M R de Vries, I Bot, P J van Santbrink, A Redeker, Z Mallat, C J Binder, R Arens, J W Jukema, J Kuiper, P H A Quax. 1. From the Department of Surgery (J.C.K., M.M.E., M.R.d.V., J.W.J., P.H.A.Q.), Einthoven Laboratory for Experimental Vascular Medicine (J.C.K., M.M.E., M.R.d.V., P.H.A.Q.), Department of Cardiology (M.M.E., J.W.J.), and Department of Immunohematology and Blood Transfusion (A.R., R.A.), Leiden University Medical Center, Leiden, The Netherlands; Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands (S.C.A.d.J.); Division of Biopharmaceutics, Leiden Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands (S.C.A.d.J., I.B., P.J.v.S., J.K.); Inserm U970, Paris Cardiovascular Research Center, Paris, France (Z.M.); Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria (C.J.B.); and Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, Vienna, Austria (C.J.B.).
Abstract
OBJECTIVE: In atherosclerosis, Toll-like receptors (TLRs) are traditionally linked to effects on tissue macrophages or foam cells. RP105, a structural TLR4 homolog, is an important regulator of TLR signaling. The effects of RP105 on TLR signaling vary for different leukocyte subsets known to be involved in atherosclerosis, making it unique in its role of either suppressing (in myeloid cells) or enhancing (in B cells) TLR-regulated inflammation in different cell types. We aimed to identify a role of TLR accessory molecule RP105 on circulating cells in atherosclerotic plaque formation. APPROACH AND RESULTS: Irradiated low density lipoprotein receptor deficient mice received RP105(-/-) or wild-type bone marrow. RP105(-/-) chimeras displayed a 57% reduced plaque burden. Interestingly, total and activated B-cell numbers were significantly reduced in RP105(-/-) chimeras. Activation of B1 B cells was unaltered, suggesting that RP105 deficiency only affected inflammatory B2 B cells. IgM levels were unaltered, but anti-oxidized low-density lipoprotein and anti-malondialdehyde-modified low-density lipoprotein IgG2c antibody levels were significantly lower in RP105(-/-) chimeras, confirming effects on B2 B cells rather than B1 B cells. Moreover, B-cell activating factor expression was reduced in spleens of RP105(-/-) chimeras. CONCLUSIONS: RP105 deficiency on circulating cells results in an intriguing unexpected TLR-associated mechanisms that decrease atherosclerotic lesion formation with alterations on proinflammatory B2 B cells.
OBJECTIVE: In atherosclerosis, Toll-like receptors (TLRs) are traditionally linked to effects on tissue macrophages or foam cells. RP105, a structural TLR4 homolog, is an important regulator of TLR signaling. The effects of RP105 on TLR signaling vary for different leukocyte subsets known to be involved in atherosclerosis, making it unique in its role of either suppressing (in myeloid cells) or enhancing (in B cells) TLR-regulated inflammation in different cell types. We aimed to identify a role of TLR accessory molecule RP105 on circulating cells in atherosclerotic plaque formation. APPROACH AND RESULTS: Irradiated low density lipoprotein receptor deficient mice received RP105(-/-) or wild-type bone marrow. RP105(-/-) chimeras displayed a 57% reduced plaque burden. Interestingly, total and activated B-cell numbers were significantly reduced in RP105(-/-) chimeras. Activation of B1 B cells was unaltered, suggesting that RP105 deficiency only affected inflammatory B2 B cells. IgM levels were unaltered, but anti-oxidized low-density lipoprotein and anti-malondialdehyde-modified low-density lipoprotein IgG2c antibody levels were significantly lower in RP105(-/-) chimeras, confirming effects on B2 B cells rather than B1 B cells. Moreover, B-cell activating factor expression was reduced in spleens of RP105(-/-) chimeras. CONCLUSIONS:RP105 deficiency on circulating cells results in an intriguing unexpected TLR-associated mechanisms that decrease atherosclerotic lesion formation with alterations on proinflammatory B2 B cells.
Entities:
Keywords:
B lymphocytes; Toll-like receptors; atherosclerosis; immune system; immunology; inflammation
Authors: Jonathan D Stallings; Danielle L Ippolito; Vineet Rakesh; Christine E Baer; William E Dennis; Bryan G Helwig; David A Jackson; Lisa R Leon; John A Lewis; Jaques Reifman Journal: BMC Genomics Date: 2014-12-03 Impact factor: 3.969
Authors: Anouk Wezel; Margreet R de Vries; Johanna M Maassen; Peter Kip; Erna A Peters; Jacco C Karper; Johan Kuiper; Ilze Bot; Paul H A Quax Journal: Sci Rep Date: 2016-04-07 Impact factor: 4.379
Authors: Taisiya Bezhaeva; ChunYu Wong; Margreet R de Vries; Eric P van der Veer; Carla M A van Alem; Ivo Que; Reshma A Lalai; Anton-Jan van Zonneveld; Joris I Rotmans; Paul H A Quax Journal: Sci Rep Date: 2017-08-31 Impact factor: 4.379